Nc 1 cell therapy (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 117 | Syringomyelia | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02807142 (ClinicalTrials.gov) | March 2016 | 3/6/2016 | Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia | Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia | Post-Traumatic Syringomyelia | Biological: NC 1 cell therapy | Puerta de Hierro University Hospital | NULL | Completed | 18 Years | 70 Years | All | 6 | Phase 2 | NULL |